Loading...
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation
BACKGROUND: The EML4–ALK (echinoderm microtubule-associated protein-like 4 gene and the anaplastic lymphoma kinase gene) fusion oncogene represents a novel molecular target in a small subset of non–small–cell lung cancers (NSCLCs). The EML4–ALK fusion gene occurs generally in NSCLC without mutations...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2013
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3671182/ https://ncbi.nlm.nih.gov/pubmed/23714228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-262 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|